Development of a sputum biomarker panel to diagnose different types of asthma
- Conditions
- asthmaTherapeutic area: Body processes [G] - Immune system processes [G12]
- Registration Number
- EUCTR2011-000924-14-BE
- Lead Sponsor
- KU Leuven LRD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
steroid naive asthmatics
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 40
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
viral/bacterial/fungal infection +fever(<1month)
asthma exacerbation (<3months)
other airway diseases (CF, ciliary dyskinesia, bronchiectasis)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method